Roberto Freilone

1.3k total citations
46 papers, 591 citations indexed

About

Roberto Freilone is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Roberto Freilone has authored 46 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pathology and Forensic Medicine, 21 papers in Genetics and 18 papers in Oncology. Recurrent topics in Roberto Freilone's work include Lymphoma Diagnosis and Treatment (30 papers), Chronic Lymphocytic Leukemia Research (15 papers) and CNS Lymphoma Diagnosis and Treatment (10 papers). Roberto Freilone is often cited by papers focused on Lymphoma Diagnosis and Treatment (30 papers), Chronic Lymphocytic Leukemia Research (15 papers) and CNS Lymphoma Diagnosis and Treatment (10 papers). Roberto Freilone collaborates with scholars based in Italy, Germany and United States. Roberto Freilone's co-authors include Barbara Botto, Umberto Vitolo, M Bertini, Lorella Orsucci, L Resegotti, Alessandro Levis, Domenico Novero, Gianluca Gaïdano, Ernesta Audisio and Paolo Gavarotti and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Roberto Freilone

43 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberto Freilone Italy 13 420 321 230 151 94 46 591
Magdalena Adde Sweden 5 502 1.2× 385 1.2× 203 0.9× 186 1.2× 42 0.4× 6 630
J O Armitage United States 7 493 1.2× 298 0.9× 214 0.9× 134 0.9× 43 0.5× 9 609
Joseph M. Connors Canada 6 620 1.5× 387 1.2× 225 1.0× 251 1.7× 63 0.7× 7 764
Judith Huerta‐Guzmán Mexico 17 400 1.0× 400 1.2× 97 0.4× 116 0.8× 133 1.4× 42 666
David Straus United States 6 467 1.1× 280 0.9× 154 0.7× 93 0.6× 40 0.4× 8 536
Fiona Miall United Kingdom 13 575 1.4× 435 1.4× 304 1.3× 148 1.0× 48 0.5× 32 758
Caroline Kuhlman United States 8 338 0.8× 301 0.9× 130 0.6× 65 0.4× 135 1.4× 12 596
Niklas Gebauer Germany 14 280 0.7× 390 1.2× 171 0.7× 106 0.7× 37 0.4× 68 660
Barbara Vannata Italy 12 347 0.8× 237 0.7× 136 0.6× 60 0.4× 71 0.8× 23 584
Luciano Guardigni Italy 7 457 1.1× 361 1.1× 145 0.6× 152 1.0× 34 0.4× 11 560

Countries citing papers authored by Roberto Freilone

Since Specialization
Citations

This map shows the geographic impact of Roberto Freilone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Freilone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Freilone more than expected).

Fields of papers citing papers by Roberto Freilone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Freilone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Freilone. The network helps show where Roberto Freilone may publish in the future.

Co-authorship network of co-authors of Roberto Freilone

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Freilone. A scholar is included among the top collaborators of Roberto Freilone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Freilone. Roberto Freilone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Novo, Mattia, C. Savelli, Barbara Botto, & Roberto Freilone. (2025). Efficacia e tossicità di brexucabtagene autoleucel nel trattamento del linfoma mantellare ad alto rischio: descrizione di un caso clinico. Recenti Progressi in Medicina. 116(3). e45–e49.
2.
Luminari, Stefano, Annalisa Chiappella, Alice Di Rocco, et al.. (2025). Overcoming barriers to referral for CAR T-cell therapy in patients with non-Hodgkin aggressive B-cell lymphomas: A Delphi consensus. Cytotherapy. 27(11). 1316–1325.
3.
Matteo, Sergio Di, et al.. (2024). Cost-Utility Analysis Comparing Pegcetacoplan to Anti-C5 Monoclonal Antibodies in the Treatment of Paroxysmal Nocturnal Hemoglobinuria. ClinicoEconomics and Outcomes Research. Volume 16. 225–232.
4.
Savelli, C., Carola Boccomini, Maura Nicolosi, et al.. (2024). Bispecific Antibodies for Lymphoid Malignancy Treatment. Cancers. 17(1). 94–94. 3 indexed citations
5.
Savelli, C., Maura Nicolosi, Carola Boccomini, et al.. (2024). Advances in Hodgkin Lymphoma Treatment: From Molecular Biology to Clinical Practice. Cancers. 16(10). 1830–1830. 6 indexed citations
6.
D’Ardìa, Stefano, Chiara Frairia, Valentina Giai, et al.. (2023). Sorafenib in combination with intensive chemotherapy for relapsed or refractory FLT3-ITD positive acute myeloid leukemia: A two centers experience. Leukemia Research. 136. 107421–107421. 1 indexed citations
7.
Frairia, Chiara, Emanuela Messa, Alessandro Busca, et al.. (2023). Validation of National Early Warning Score and Quick Sequential (sepsis‐related) Organ Failure Assessment in acute myeloid leukaemia patients treated with intensive chemotherapy. European Journal Of Haematology. 110(6). 696–705. 5 indexed citations
8.
Savelli, C., Barbara Botto, Federica Cavallo, et al.. (2023). Chimeric Antigen Receptor-T Cell Therapy for Lymphoma: New Settings and Future Directions. Cancers. 16(1). 46–46. 6 indexed citations
9.
Freilone, Roberto, Benedetto Bruno, Ernesta Audisio, et al.. (2023). Thrombosis in Acute Myeloid Leukemia: Pathogenesis, Risk Factors and Therapeutic Challenges. Current Treatment Options in Oncology. 24(6). 693–710. 7 indexed citations
10.
Arrigo, Giulia, Stefano D’Ardìa, Ernesta Audisio, et al.. (2022). Gilteritinib in Isolated Breast Relapse of <b><i>FLT3</i></b> Positive Acute Myeloid Leukemia: A Case Report and Review of Literature. Acta Haematologica. 145(5). 566–570. 5 indexed citations
11.
Cerrano, Marco, Daniela Di Cuonzo, Stefano D’Ardìa, et al.. (2022). Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study. Annals of Hematology. 101(4). 855–867. 29 indexed citations
12.
Federico, Massimo, Stefano Luminari, Alessandra Dondi, et al.. (2012). R-CVP versus R-CHOP versus R-FM as first-line therapy for advanced-stage follicular lymphoma: Final results of FOLL05 trial from the Fondazione Italiana Linfomi (FIL). American Journal of Clinical Oncology. 6 indexed citations
13.
Federico, Massimo, Stefano Luminari, Alessandra Dondi, et al.. (2012). R-CVP versus R-CHOP versus R-FM as first-line therapy for advanced-stage follicular lymphoma: Final results of FOLL05 trial from the Fondazione Italiana Linfomi (FIL).. Journal of Clinical Oncology. 30(15_suppl). 8006–8006. 12 indexed citations
14.
15.
16.
Ricardi, Umberto, Andrea Riccardo Filippi, Alessandra Cuttica, et al.. (2005). Rituximab followed by localized radiation therapy in limited stage indolent non-Hodgkin’s lymphoma: Preliminary results of a pilot study. Journal of Clinical Oncology. 23(16_suppl). 6696–6696. 1 indexed citations
17.
Vitolo, Umberto, Gianluca Gaïdano, Barbara Botto, et al.. (1998). Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: Clinical relevance in 71 patients. Annals of Oncology. 9(1). 55–61. 79 indexed citations
18.
Vitolo, Umberto, Anna Marina Liberati, Roberto Freilone, et al.. (1997). Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma.. Journal of Clinical Oncology. 15(2). 491–498. 52 indexed citations
19.
Freilone, Roberto, Barbara Botto, Umberto Vitolo, et al.. (1996). Combined modality treatment with a weekly brief chemotherapy (ACOP-B) followed by locoregional radiotherapy in localized-stage intermediate- to high-grade non-Hodgkin's lymphoma. Annals of Oncology. 7(9). 919–924. 9 indexed citations
20.
Volpe, Gisella, Umberto Vitolo, Antonino Carbone, et al.. (1996). Molecular heterogeneity of B-lineage diffuse large cell lymphoma. Genes Chromosomes and Cancer. 16(1). 21–30. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Magdalena Adde Breakdown of academic impact, for papers by J O Armitage Breakdown of academic impact, for papers by Joseph M. Connors Breakdown of academic impact, for papers by Judith Huerta‐Guzmán Breakdown of academic impact, for papers by David Straus Breakdown of academic impact, for papers by Fiona Miall Breakdown of academic impact, for papers by Caroline Kuhlman Breakdown of academic impact, for papers by Niklas Gebauer Breakdown of academic impact, for papers by Barbara Vannata Breakdown of academic impact, for papers by Luciano Guardigni
Rankless by CCL
2026